Search by Drug Name or NDC

    NDC 50458-0940-01 INVOKAMET XR 50; 500 mg/1; mg/1 Details

    INVOKAMET XR 50; 500 mg/1; mg/1

    INVOKAMET XR is a ORAL TABLET, FILM COATED, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Janssen Pharmaceuticals, Inc.. The primary component is CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE.

    Product Information

    NDC 50458-0940
    Product ID 50458-940_004d0398-3384-8623-e063-6394a90aaae7
    Associated GPIs 27996002207520
    GCN Sequence Number 076620
    GCN Sequence Number Description canagliflozin/metformin HCl TAB BP 24H 50MG-500MG ORAL
    HIC3 C4E
    HIC3 Description ANTIHYPERGLYCEMIC-SGLT2 INHIBITOR-BIGUANIDE COMBS.
    GCN 42312
    HICL Sequence Number 041287
    HICL Sequence Number Description CANAGLIFLOZIN/METFORMIN HCL
    Brand/Generic Brand
    Proprietary Name INVOKAMET XR
    Proprietary Name Suffix n/a
    Non-Proprietary Name canagliflozin and metformin hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 50; 500
    Active Ingredient Units mg/1; mg/1
    Substance Name CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
    Labeler Name Janssen Pharmaceuticals, Inc.
    Pharmaceutical Class Biguanide [EPC], Biguanides [CS], P-Glycoprotein Inhibitors [MoA], Sodium-Glucose Cotransporter 2 Inhibitor [EPC], Sodium-Glucose Transporter 2 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA205879
    Listing Certified Through 2024-12-31

    Package

    NDC 50458-0940-01 (50458094001)

    NDC Package Code 50458-940-01
    Billing NDC 50458094001
    Package 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-940-01)
    Marketing Start Date 2016-09-20
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 8.70288
    Pricing Unit EA
    Effective Date 2021-01-15
    NDC Description INVOKAMET XR 50-500 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 4
    Classification for Rate Setting B
    As of Date 2022-01-12
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis